Fisher Asset Management LLC Reduces Stock Position in Haleon plc (NYSE:HLN)

Fisher Asset Management LLC reduced its holdings in shares of Haleon plc (NYSE:HLN) by 96.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 438,995 shares of the company’s stock after selling 13,243,267 shares during the period. Fisher Asset Management LLC’s holdings in Haleon were worth $4,188,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Wealth Enhancement Advisory Services LLC boosted its stake in Haleon by 3.0% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 61,016 shares of the company’s stock valued at $646,000 after acquiring an additional 1,766 shares during the last quarter. Farther Finance Advisors LLC raised its stake in shares of Haleon by 33.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 10,936 shares of the company’s stock valued at $116,000 after purchasing an additional 2,715 shares in the last quarter. Janney Montgomery Scott LLC lifted its position in shares of Haleon by 13.9% during the third quarter. Janney Montgomery Scott LLC now owns 750,897 shares of the company’s stock worth $7,944,000 after purchasing an additional 91,610 shares during the last quarter. QRG Capital Management Inc. grew its stake in Haleon by 20.9% in the third quarter. QRG Capital Management Inc. now owns 201,934 shares of the company’s stock worth $2,136,000 after purchasing an additional 34,884 shares in the last quarter. Finally, PDS Planning Inc increased its holdings in Haleon by 17.5% in the third quarter. PDS Planning Inc now owns 16,409 shares of the company’s stock valued at $174,000 after buying an additional 2,443 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on HLN. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $10.95.

Haleon Price Performance

HLN opened at $10.68 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The company’s 50-day moving average price is $9.61 and its 200 day moving average price is $9.84. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The firm has a market cap of $48.33 billion, a price-to-earnings ratio of 31.40, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28.

Haleon (NYSE:HLN) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The business had revenue of $3.54 billion for the quarter, compared to analysts’ expectations of $3.38 billion. As a group, sell-side analysts expect that Haleon plc will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The company also recently declared a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This is an increase from Haleon’s previous — dividend of $0.05. The ex-dividend date is Friday, April 25th. This represents a dividend yield of 1.6%. Haleon’s payout ratio is 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.